Preliminary results from a phase II study of lenalidomide oral monotherapy in relapsed/refractory aggressive non-Hodgkin lymphoma

被引：0
|
作者：
Wiernik, P. H.
Lossos, I. S.
Tuscano, J.
Justice, G.
Vose, J. M.
Pietronigro, D.
Takeshita, K.
Ervin-Haynes, A.
Zeldis, J.
Habermann, T.
机构：
[1] New York Med Coll, Bronx, NY USA
[2] Univ Miami, Miami, FL USA
[3] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
[4] Pacific Coast Hematol Oncol Med Grp, Fountain Valley, CA USA
[5] Univ Nebraska, Omaha, NE 68182 USA
[6] Celgene Corp, Summit, NJ USA
[7] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8052
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Preliminary results from a phase II study of lenalidomide oral monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
    Witzig, T. E.
    Vose, J.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J.
    Wiernik, P. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Preliminary results from a phase II study of lenalidomide monotherapy in Relapsed/Refractory aggressive non-Hodgkin's lymphoma.
    Wiemik, Peter H.
    Lossos, Izidore
    Tuscano, Joseph
    Justice, Glen
    Vose, Julie M.
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Habermann, Thomas M.
    BLOOD, 2006, 108 (11) : 160A - 161A
  • [3] Results from a phase II study of lenalidomide oral monotherapy in relapsed/refractory indolent non-Hodgkin's lymphoma
    Witzig, Thomas E.
    Vose, Julie M.
    Moore, Timothy D.
    Reeder, Craig B.
    Cole, Craig E.
    Justice, Glen
    Kaplan, Henry P.
    Voralia, Michael
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Wiernik, Peter H.
    BLOOD, 2007, 110 (11) : 754A - 755A
  • [4] Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
    Wiernik, Peter H.
    Lossos, Izidore S.
    Tuscano, Joseph M.
    Justice, Glen
    Vose, Julie M.
    Cole, Craig E.
    Lam, Wendy
    McBride, Kyle
    Wride, Kenton
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Habermann, Thomas M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4952 - 4957
  • [5] RESULTS FROM A PHASE 11 TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF LENALIDOMIDE ORAL MONOTHERAPY IN RELAPSED OR REFRACTORY AGGRESSIVE NON-HODGKIN'S LYMPHOMA
    Peter, H. W.
    Lossos, L. S.
    Tuscano, J.
    Justice, G.
    Vose, J. M.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J. B.
    Habermann, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 306 - 306
  • [6] Phase II trial for lenalidomide alone in relapsed/refractory aggressive non-Hodgkin lymphoma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (05): : 339 - 339
  • [7] Early results from a phase II study of lenalidomide monotherapy in relapsed/refractory indolent non-Hodgkin's lymphoma.
    Wilzig, Thomas E.
    Vose, Julie M.
    Kaplan, Henry P.
    Wolf, Jeffrey Lee
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Wiernik, Peter H.
    BLOOD, 2006, 108 (11) : 703A - 703A
  • [8] Lenalidomide oral monotherapy in relapsed/refractory small lymphocytic non-Hodgkin's lymphoma
    Witzig, T. E.
    Vose, J. M.
    Justice, G.
    Kaplan, H. G.
    Reeder, C. B.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J. B.
    Wiernik, P. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] International study of lenalidomide in relapsed/refractory aggressive non-Hodgkin's lymphoma
    Czuczman, M. S.
    Reeder, C. B.
    Polikoff, J.
    Chowhan, N. M.
    Esseessee, I.
    Greenberg, R.
    Ervin-Haynes, A.
    Pietronigro, D.
    Zeldis, J. B.
    Witzig, T. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Brentuximab vedotin for relapsed or refractory non-Hodgkin lymphoma: Preliminary results from a phase II study.
    Advani, Ranjana
    Oki, Yasuhiro
    Shustov, Andrei R.
    Grove, Laurie E.
    Bartlett, Nancy
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345